Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

NPY Y5 receptor antagonist suppresses feeding and reduces body weight in rodents

Aug. 13, 1998

Sumitomo proves cardioprotective activity of Na+/H+ exchange inhibitor SM-20550

Aug. 12, 1998

Profile of Solvay's dual NEP/ECE inhibitor in clinical testing

Aug. 12, 1998

French team discovers ciproxifan, a histaminergic agent with clinical potential in AD

Aug. 12, 1998

NQ-304, a novel platelet antiaggregatory and antithrombotic agent in early development

Aug. 12, 1998

Menarini's NK1 antagonist MEN-11467 shows promising antiasthmatic activity

Aug. 12, 1998

Dual ETA/ETB antagonist provides effective blood pressure control in rats

Aug. 11, 1998

OPC-51803, a vasopressin V2 agonist with potent antidiuretic activity in rats and dogs

Aug. 11, 1998

RS-601, a dual-action TxA2/LTD4 antagonist with potent antiasthmatic effects

Aug. 11, 1998

New antiplatelet agent, PDE III inhibitor, reported by Taiwanese scientists

Aug. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.